Evidence map›Paper›PMID 38228634›Full record

ArticleNature communications2024

A Machine Learning-Driven Virtual Biopsy System For Kidney Transplant Patients.

Daniel Yoo, Gillian Divard, Marc Raynaud, Aaron Cohen, Tom D Mone, John Thomas Rosenthal, Andrew J Bentall, Mark D Stegall, Maarten Naesens, Huanxi Zhang and 29 more

Registry-linked trialAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06505200 (An Integrative Clinicopathological Decision Support System for Kidney Transplant Rejection), which is not on this map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06505200 active not recruitingnot on this map

An Integrative Clinicopathological Decision Support System for Kidney Transplant Rejection

TypeobservationalSponsorUniversitaire Ziekenhuizen KU LeuvenRan2004 to 2027Enrolled1,891ConditionsKidney Transplant Rejection, Kidney Transplantation, Kidney Transplant FailureArmsNo intervention
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Understanding Machine Learning Applications in Lung Transplantation: A Narrative Review.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors.

Daniel Yoo *Université Paris Cité, INSERM U970 PARCC, Paris Institute for Transplantation and Organ Regeneration, F-75015, Paris, France.
Gillian Divard *Université Paris Cité, INSERM U970 PARCC, Paris Institute for Transplantation and Organ Regeneration, F-75015, Paris, France.
Marc RaynaudUniversité Paris Cité, INSERM U970 PARCC, Paris Institute for Transplantation and Organ Regeneration, F-75015, Paris, France.
Aaron CohenOneLegacy, Los Angeles, CA, USA.
Tom D MoneOneLegacy, Los Angeles, CA, USA.
John Thomas RosenthalDavid Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Andrew J BentallDivision of Nephrology and Hypertension, Mayo Clinic Transplant Center, Rochester, MN, USA.ORCID 0000-0002-8495-9782
Mark D StegallDepartment of Surgery, Mayo Clinic, Rochester, MN, USA.
Maarten NaesensDepartment of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Huanxi ZhangOrgan Transplant Center, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Changxi WangOrgan Transplant Center, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Juliette GueguenNéphrologie-Immunologie Clinique, Hôpital Bretonneau, CHU Tours, Tours, France.
Nassim KamarDepartment of Nephrology and Organ Transplantation, Paul Sabatier University, INSERM, Toulouse, France.
Antoine BouquegneauDepartment of Nephrology-Dialysis-Transplantation, Centre hospitalier universitaire de Liège, Liège, Belgium.
Ibrahim BatalDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0002-0686-5457
Shana M ColeyDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA.
John S GillDivision of Nephrology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Federico OppenheimerKidney Transplant Department, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain.
Erika De Sousa-AmorimKidney Transplant Department, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain.
Dirk R J KuypersDepartment of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Antoine DurrbachDepartment of Nephrology, AP-HP Hôpital Henri Mondor, Créteil, Île de France, France.
Daniel SeronNephrology Department, Hospital Vall d'Hebrón, Autonomous University of Barcelona, Barcelona, Spain.
Marion RabantDepartment of Pathology, Necker-Enfants Malades Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Jean-Paul Duong Van HuyenUniversité Paris Cité, INSERM U970 PARCC, Paris Institute for Transplantation and Organ Regeneration, F-75015, Paris, France.
Patricia CampbellFaculty of Medicine & Dentistry - Laboratory Medicine & Pathology Dept, University of Alberta, Edmonton, AB, Canada.
Soroush ShojaiFaculty of Medicine & Dentistry - Laboratory Medicine & Pathology Dept, University of Alberta, Edmonton, AB, Canada.ORCID 0000-0002-2969-9121
Michael MengelFaculty of Medicine & Dentistry - Laboratory Medicine & Pathology Dept, University of Alberta, Edmonton, AB, Canada.ORCID 0000-0002-7222-3356
Oriol BestardNephrology Department, Hospital Vall d'Hebrón, Autonomous University of Barcelona, Barcelona, Spain.
Nikolina Basic-JukicDepartment of nephrology, arterial hypertension, dialysis and transplantation, University Hospital Centre Zagreb, Zagreb, Croatia.
Ivana JurićDepartment of nephrology, arterial hypertension, dialysis and transplantation, University Hospital Centre Zagreb, Zagreb, Croatia.
Peter BoorInstitute of Pathology, RWTH Aachen University Hospital, Aachen, Germany.ORCID 0000-0001-9921-4284
Lynn D CornellDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Mariam P AlexanderDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-9072-9871
P Toby CoatesDepartment of Renal and Transplantation, University of Adelaide, Royal Adelaide Hospital Campus, Adelaide, SA, Australia.ORCID 0000-0003-0342-8179
Christophe LegendreUniversité Paris Cité, INSERM U970 PARCC, Paris Institute for Transplantation and Organ Regeneration, F-75015, Paris, France.
Peter P ReeseUniversité Paris Cité, INSERM U970 PARCC, Paris Institute for Transplantation and Organ Regeneration, F-75015, Paris, France.
Carmen LefaucheurUniversité Paris Cité, INSERM U970 PARCC, Paris Institute for Transplantation and Organ Regeneration, F-75015, Paris, France.
Olivier AubertUniversité Paris Cité, INSERM U970 PARCC, Paris Institute for Transplantation and Organ Regeneration, F-75015, Paris, France.
Alexandre LoupyUniversité Paris Cité, INSERM U970 PARCC, Paris Institute for Transplantation and Organ Regeneration, F-75015, Paris, France. alexandre.loupy@inserm.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In kidney transplantation, day-zero biopsies are used to assess organ quality and discriminate between donor-inherited lesions and those acquired post-transplantation. However, many centers do not perform such biopsies since they are invasive, costly and may delay the transplant procedure. We aim to generate a non-invasive virtual biopsy system using routinely collected donor parameters. Using 14,032 day-zero kidney biopsies from 17 international centers, we develop a virtual biopsy system. 11 basic donor parameters are used to predict four Banff kidney lesions: arteriosclerosis, arteriolar hyalinosis, interstitial fibrosis and tubular atrophy, and the percentage of renal sclerotic glomeruli. Six machine learning models are aggregated into an ensemble model. The virtual biopsy system shows good performance in the internal and external validation sets. We confirm the generalizability of the system in various scenarios. This system could assist physicians in assessing organ quality, optimizing allograft allocation together with discriminating between donor derived and acquired lesions post-transplantation.

Indexed as

Kidney DiseasesKidney TransplantationBiopsyHumansKidneyTransplantation, Homologous

Identifiers

PMID38228634
PMCPMC10791605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.